RxDoctor Payments Data

Mohammad El-Ghanem, MD

Vascular Neurology · Houston, TXNPI 1912276221

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Stryker at 42.4% of the total. Reporting peaked in 2019 at $2,040 and has fallen 83.1% since, to $344 in 2025.

$5,110in general payments, 2019–2025

Across 45 payments — averaging $113.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Medical Device Business Services, Inc.$1K
  • Johnson & Johnson$401
  • Route 92 Medical, Inc.$309
  • Medtronic$307
  • Microvention, Inc.$304
  • plus $259 from 4 others
$22,506in research payments, 2019–2025

Across 8 payments — averaging $2813.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$13K
  • Medical Device Business Services, Inc.$10K

What the payments were for

  • Travel & lodging$2,74554%
  • Food & beverage$2,36546%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,110 in reported general payments places this provider in the 65th percentile of 76 vascular neurology providers in Texas.

See all vascular neurology providers in Texas

Medicare billing

Part B allowed, 2024
$26,336
Medicare patients
39
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular neurology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →